Investigate the Safety Tolerability and Pharmacokinetics of Multiple Doses of AZD1236

NCT00767052 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteer

Interventions

DRUG: AZD1236
DRUG: Placebo
DRUG: AZD1236
DRUG: AZD1236

Sponsor

AstraZeneca